CLINICAL TRIALS AND OBSERVATIONS Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials

نویسندگان

  • David Grimwade
  • Robert K. Hills
  • Anthony V. Moorman
  • Helen Walker
  • Stephen Chatters
  • Anthony H. Goldstone
  • Keith Wheatley
  • Christine J. Harrison
  • Alan K. Burnett
چکیده

1Department of Medical and Molecular Genetics, King’s College London School of Medicine and Department of Haematology, Guy’s & St. Thomas’ NHS Foundation Trust, London; 2Department of Haematology, Cardiff University School of Medicine, Cardiff; 3Leukaemia Research Cytogenetics Group, Northern Institute for Cancer Research, Newcastle University, Newcastle-upon-Tyne; 4Department of Haematology, University College London Hospitals, London; and 5Cancer Research United Kingdom Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

CLINICAL TRIALS AND OBSERVATIONS Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

Anthony V. Moorman,1 Christine J. Harrison,1 Georgina A. N. Buck,2 Sue M. Richards,2 Lorna M. Secker-Walker,1 Mary Martineau,1 Gail H. Vance,3 Athena M. Cherry,4 Rodney R. Higgins,5 Adele K. Fielding,6 Letizia Foroni,6 Elisabeth Paietta,7 Martin S. Tallman,8 Mark R. Litzow,9 Peter H. Wiernik,7 Jacob M. Rowe,10 Anthony H. Goldstone,11 and Gordon W. Dewald, on behalf of the Medical Research Counc...

متن کامل

CLINICAL TRIALS AND OBSERVATIONS Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group

We investigated the relative prognostic significance of cytogenetics in 635 adult acute myeloid leukemia (AML) patients 60 years of age or older treated on front-line protocols. Classification trees and treestructured survival analysis (TSSA) were used to identify important cytogenetic groups, and their prognostic significance was then assessed in multivariable analysis (MVA). Overall, 48.5% ac...

متن کامل

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Impact of trisomy 8 ( 8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study

The prognostic impact of trisomy 8, alone or with other clonal aberrations, was evaluated in 849 patients with previously untreated acute myeloid leukemia (AML) who were registered to 5 Southwest Oncology Group trials. At presentation, 108 (12.7%) patients had 8 in their karyotypes, including 43 (5.1%) patients with 8 as the sole aberration; 307 (36.2%) were normal, and 434 (51.1%) had other cy...

متن کامل

CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS Prevalence and clinical characteristics of myelodysplastic syndrome with bone marrow eosinophilia or basophilia

By retrospectively analyzing 288 patients with de novo myelodysplastic syndrome (MDS), we sought to determine the prevalence and clinical characteristics of bone marrow eosinophilia and basophilia that were detected at presentation. Bone marrow eosinophilia and basophilia were defined as a differential count of each cell type exceeding 5.0% and 1.0%, respectively. Of 288 patients with MDS, 36 (...

متن کامل

CLINICAL TRIALS AND OBSERVATIONS Efficacy of tyrosine kinase inhibitors (TKIs) as third-line therapy in patients with chronic myeloid leukemia in chronic phase who have failed 2 prior lines of TKI therapy

We analyzed a cohort of 26 patients with chronic myeloid leukemia who had failed imatinib and a second tyrosine kinase inhibitor but were still in first chronic phase and identified prognostic factors for response and outcomes. The achievement of a prior cytogenetic response on imatinib or on second-line therapy were the only independent predictors for the achievement of complete cytogenetic re...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2010